Paracetamol's Safety in Pregnancy: Debunking Trump's Autism Claims
A recent study published in The Lancet Obstetrics, Gynaecology & Women's Health has provided compelling evidence that contradicts former US President Donald Trump's controversial statements about paracetamol's safety during pregnancy. The research, conducted by experts, analyzed 43 high-quality studies involving hundreds of thousands of women, and found no link between paracetamol use and an increased risk of autism, ADHD, or developmental issues in children.
The findings offer reassurance to pregnant women, as they align with the guidance from major medical organizations worldwide. This is particularly significant given Trump's alarming claims that paracetamol is harmful and pregnant women should avoid it at all costs. These statements caused confusion and concern among healthcare professionals and pregnant women alike.
The study's lead author, Professor Asma Khalil, emphasizes the safety of paracetamol during pregnancy when used as directed. She highlights that any previous associations between the drug and autism are likely due to other factors, not the paracetamol itself. This is crucial information, as paracetamol is the recommended pain reliever for pregnant women experiencing pain or fever.
Medical experts not involved in the study have welcomed the findings, expressing relief that women no longer need to worry about the potential harmful effects of a common pain reliever on their children's health. Professor Grainne McAlonnan from King's College London emphasizes the importance of this research in bringing closure to the matter.
The study's rigorous methodology, which excluded lower-quality studies and considered important factors like underlying illnesses, adds to its credibility. Professor Ian Douglas from the London School of Hygiene and Tropical Medicine praises the review's well-conducted approach. Additionally, molecular neuroscientist Professor Jan Haavik believes the study provides strong evidence that paracetamol use during pregnancy does not increase the risk of autism, ADHD, or intellectual disability, effectively ending the debate.
Despite these findings, it's important to note that some US health officials and experts still express concerns. A 2025 review led by Dr. Andrew Baccarelli found a potential link between acetaminophen (the US name for paracetamol) and increased autism and ADHD risks, although it recommended caution against heavy or prolonged use. This review prompted the US Food and Drug Administration (FDA) to issue a cautious letter to clinicians, while also acknowledging paracetamol as the approved drug for fever treatment during pregnancy.
The FDA's website clarifies that a causal relationship between paracetamol and neurological conditions has not been established. UK health officials, however, strongly support the safety of paracetamol as the safest painkiller for pregnant women, aligning with the study's conclusions.
